Evidence map›Paper›PMID 39552910›Full record

ArticleJournal of thoracic disease2024

The effect of bronchoscopic lung volume reduction on the bronchodilator response.

Firas Ido, Michael DiRico, Meng-Shan Lin, Deborah Stahlnecker

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Firas IdoDepartment of Pulmonary and Critical Care Medicine, St. Luke's University Health Network, Bethlehem, PA, USA.ORCID https://orcid.org/0000-0001-5049-5433
Michael DiRicoDepartment of Pulmonary and Critical Care Medicine, St. Luke's University Health Network, Bethlehem, PA, USA.
Meng-Shan LinDepartment of Pulmonary and Critical Care Medicine, St. Luke's University Health Network, Bethlehem, PA, USA.
Deborah StahlneckerDepartment of Pulmonary and Critical Care Medicine, St. Luke's University Health Network, Bethlehem, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bronchoscopic lung volume reduction (BLVR) is a method of achieving lung collapse in severely emphysematous regions. One of the measures of success is the improvement in post-bronchodilator forced expiratory volume in the first second (FEV Methods: We performed a retrospective study to analyze the change in BDR following BLVR. We included patients who underwent pulmonary function test (PFT) within 6 months of BLVR and confirmed complete lobar atelectasis. The pre-BLVR BDR for each patient served as the control, which was then compared to the post-BLVR BDR. The mean difference in the BDR before and after valve placement was determined. The comparison between pre- and post-BLVR means was performed using a Results: A total of 35 patients were assessed for the study. Fifteen patients were excluded (due to valve removal, incomplete lobar collapse, and no pre- or post-BLVR PFT available). Of the 20 remaining patients, 14 had a positive BDR at baseline before BLVR. Following BLVR, 13 of the 14 patients demonstrated a non-significant increase in the BDR. The mean BDR for pre- and post-valve was 83.6 Conclusions: BLVR may improve the BDR in patients with complete lobar atelectasis.

Indexed as

Bronchodilator response (BDR)bronchoscopic lung volume reduction (BLVR)chronic obstructive pulmonary disease (COPD)endobronchial valves

Identifiers

PMID39552910
PMCPMC11565302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.